Overview

Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting

Status:
Unknown status
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of S-1 and oxaliplatin combined with radiation by Phase I/II study. The purpose of this study is as follows, - In phase I, to determine the dose limiting toxicities (DLTs) and the maximum tolerated dose (MTD). - In phase II, to evaluate the antitumor effect (pCR rate) and the safety .
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Japan Clinical Cancer Research Organization
Collaborator:
Taiho Pharmaceutical Co., Ltd.
Treatments:
Oxaliplatin